» Articles » PMID: 17266963

Prevalence of the Metabolic Syndrome is Increased in Rheumatoid Arthritis and is Associated with Coronary Atherosclerosis

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2007 Feb 3
PMID 17266963
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with rheumatoid arthritis (RA) have accelerated atherosclerosis. The metabolic syndrome, a cluster of cardiovascular risk factors, identifies cardiovascular risk. We tested the hypotheses that patients with RA have a higher prevalence of the metabolic syndrome, particularly the WHO-defined syndrome that requires insulin resistance, and that this is associated with coronary atherosclerosis. The prevalence of the metabolic syndrome was determined using the modified WHO and NCEP III criteria in 154 patients with RA (88 with early RA and 66 with long-standing RA) and 85 control subjects. Coronary-artery atherosclerosis was detected by electron beam computed tomography. The WHO-defined metabolic syndrome was present in 42% of patients with long-standing RA, 31% with early RA and 11% of controls (P<0.001); the NCEP-defined metabolic syndrome was present in 42% of patients with long-standing RA, 30% with early RA and 22% of controls (P=0.03). Patients with the WHO-defined metabolic syndrome had an increased risk of having higher coronary-artery calcification scores, independent of age and sex (OR=2.02, 95% CI: 1.03-3.97, P=0.04). In conclusion, patients with RA have a higher prevalence of the metabolic syndrome than control subjects. Inflammation-associated metabolic syndrome is a mechanism that may contribute to increased coronary-artery atherosclerosis in RA.

Citing Articles

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.

Saidi A, Theel W, Burggraaf B, van der Lelij A, Grobbee D, van Zeben J Clin Rheumatol. 2025; .

PMID: 39962010 DOI: 10.1007/s10067-025-07364-5.


The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis.

Jia X, Yang Z, Li J, Mei Z, Jia L, Yan C PLoS One. 2024; 19(8):e0306513.

PMID: 39208032 PMC: 11361434. DOI: 10.1371/journal.pone.0306513.


Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients.

Bagheri-Hosseinabadi Z, Moadab F, Abbasifard M BMC Endocr Disord. 2024; 24(1):140.

PMID: 39103813 PMC: 11299255. DOI: 10.1186/s12902-024-01675-5.


Association between different triglyceride-glucose index combinations with obesity indicators and arthritis: results from two nationally representative population-based study.

Zhang X, Tang H, Chen J, Chen J, Zhou H, Qi T Eur J Med Res. 2024; 29(1):389.

PMID: 39068497 PMC: 11282701. DOI: 10.1186/s40001-024-01992-4.


Cardio-Rheumatology Insights Into Hypertension: Intersection of Inflammation, Arteries, and Heart.

Akhtari S, Harvey P, Eder L Am J Hypertens. 2024; 37(12):933-942.

PMID: 39056266 PMC: 11565202. DOI: 10.1093/ajh/hpae098.